An additional trial by the Swiss Team (SAKK) enrolled cytologically or histologically proven IIIA (N2) people which have been then randomized into preoperative chemotherapy accompanied by surgical procedures versus sequential neo-adjuvant chemotherapy and after that radiotherapy followed by surgical procedure; the main and the secondary endpoints o